InvestorsHub Logo

Biobillionair

09/11/19 7:16 PM

#213862 RE: jfmcrr #213861

I see your point, but it needs better wording to not be confusing...clearly if we are confused so is the FDA. You’d think Amarin and FDA could figure this out...but not a chance in hell with the history between the two...
BB

Biobillionair

09/11/19 7:23 PM

#213864 RE: jfmcrr #213861

I see your point, but it needs better wording to not be confusing...clearly if we are confused so is the FDA. You’d think Amarin and FDA could figure this out...but not a chance in hell with the history between the two...

...separate prescription treatment option...



Is too close for a primary indication...especially with Amarin’s First Amendment win...

BB

MateoPaisa

09/11/19 7:49 PM

#213868 RE: jfmcrr #213861

That's a good interpretation, but I look at it as:

"V is not intended to compete with Statins and, therefore can be used as both an "incremental, as well as a separate treatment option... "


Meaning that it can be used with Statins or separately (without Statins)

jessellivermore

09/11/19 9:21 PM

#213882 RE: jfmcrr #213861

jf....

Quote: "Although an odd word choice, I think this means "in addition to" statin."

Sounds right to me....

":>) JL